The Department has been working continuously to ensure a stable long-term policy environment and reduce the compliance burden on the Industry.
The partnership is a significant step in delivering advanced cancer therapies to patients.
Promising drug pipeline, focus on gene therapy and innovative digital health solutions will remain the key pillars of Bayer’s pharmaceutical business
The company is expecting tremendous growth and a better quarterly performance
The Phase 2 study of Sputnik V was conducted on 100 subjects as part of the randomized, double-blind, parallel-group, placebo-controlled study in India.
Subscribe To Our Newsletter & Stay Updated
